BIO Insider Trading

Insider Ownership Percentage: 17.06%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,299,740.06

Bio-Rad Laboratories Insider Trading History Chart

This chart shows the insider buying and selling history at Bio-Rad Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1M-$500k$0$500k$1MTotal Insider BuyingTotal Insider Selling

Bio-Rad Laboratories Share Price & Price History

Current Price: $245.16
Price Change: Price Increase of +5.16 (2.15%)
As of 04/2/2025 04:58 PM ET

This chart shows the closing price history over time for BIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$239.97Closing price on 04/01/25:

SEC Filings (Institutional Ownership Changes) for Bio-Rad Laboratories (NYSE:BIO)

65.24% of Bio-Rad Laboratories stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$58ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$500M$0$500MTotal InflowsTotal Outflows
Bio-Rad Laboratories logo
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Read More on Bio-Rad Laboratories

Today's Range

Now: $245.16
Low: $237.63
High: $248.00

50 Day Range

MA: $289.28
Low: $239.97
High: $367.36

52 Week Range

Now: $245.16
Low: $235.84
High: $387.99

Volume

249,119 shs

Average Volume

292,241 shs

Market Capitalization

$6.87 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98

Who are the company insiders with the largest holdings of Bio-Rad Laboratories?

Bio-Rad Laboratories' top insider investors include:
  1. Andrew J Last (COO)
  2. Michael Crowley (EVP)
  3. Timothy S Ernst (EVP)
  4. Dara Wright (EVP)
  5. James Barry (EVP)
  6. Ajit Ramalingam (CAO)
Learn More about top insider investors at Bio-Rad Laboratories.

Who are the major institutional investors of Bio-Rad Laboratories?

Bio-Rad Laboratories' top institutional investors include:
  1. RK Asset Management LLC — 0.05%
Learn More about top institutional investors of Bio-Rad Laboratories stock.

Which institutional investors are selling Bio-Rad Laboratories stock?

In the last quarter, BIO stock was sold by these institutional investors:
  1. RK Asset Management LLC
In the last year, company insiders that have sold Bio-Rad Laboratories company stock include:
  1. Andrew J Last (COO)
  2. Michael Crowley (EVP)
  3. Timothy S Ernst (EVP)
Learn More investors selling Bio-Rad Laboratories stock.